Literature DB >> 10450729

Survival in stomach cancer is improving: results of a nationwide population-based Swedish study.

L E Hansson1, P Sparén, O Nyrén.   

Abstract

OBJECTIVE: To monitor for secular trends in survival among patients with stomach cancer. SUMMARY BACKGROUND DATA: The overall survival among patients with stomach cancer has remained stable at a low level for several decades.
METHODS: Relative survival was estimated for all 53,862 living patients reported from 1960 to 1989 to the Swedish Cancer Registry, which is nationwide and virtually complete, with compulsory reporting of new cases of stomach cancer. Follow-up was from cancer diagnosis until death, emigration, or December 31, 1991.
RESULTS: During the 1980s, statistically significant improvements were seen in the 2-month, 5-year, and 10-year relative survival of patients with stomach cancer, and in the subgroup with noncardiac cancer. The 5-year relative survival rate increased from 13.3% (95% confidence interval [CI] 12.4 to 14.1) among patients diagnosed with noncardiac stomach cancer in 1970-1974 to 19.4% (95% CI 18.1-20.7) among those given this diagnosis in 1985-1986; the overall mean life expectancy increased from 2.2 to 3.3 years. In patients with cancer of the gastric cardia, the 5-year relative survival rate increased from 4.7% (95% CI 2.3-7.1) to 10.4% (95% CI 7.7-13.1), but the 10-year relative survival rate did not improve. The overall mean life expectancy in this group increased from 1.4 to 2.2 years. Age at diagnosis was strongly and inversely related to relative survival. Patients diagnosed at university hospitals had a moderate survival advantage.
CONCLUSION: The survival of patients with a stomach cancer diagnosis appears to be increasing. The reasons for this are probably multifactorial and are likely to include improvements in surgical and anesthesiologic management. However, the long-term prognosis of cancer of the gastric cardia remains dismal.

Entities:  

Mesh:

Year:  1999        PMID: 10450729      PMCID: PMC1420858          DOI: 10.1097/00000658-199908000-00005

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  43 in total

1.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION.

Authors:  P LAUREN
Journal:  Acta Pathol Microbiol Scand       Date:  1965

2.  The decline in the incidence of stomach cancer in Sweden 1960-1984: a birth cohort phenomenon.

Authors:  L E Hansson; R Bergström; P Sparén; H O Adami
Journal:  Int J Cancer       Date:  1991-02-20       Impact factor: 7.396

3.  Randomized comparison of R1 and R2 gastrectomy for gastric carcinoma.

Authors:  D M Dent; M V Madden; S K Price
Journal:  Br J Surg       Date:  1988-02       Impact factor: 6.939

4.  Postoperative morbidity and mortality after D1 and D2 resections for gastric cancer: preliminary results of the MRC randomised controlled surgical trial. The Surgical Cooperative Group.

Authors:  A Cuschieri; P Fayers; J Fielding; J Craven; J Bancewicz; V Joypaul; P Cook
Journal:  Lancet       Date:  1996-04-13       Impact factor: 79.321

5.  [Diagnostic and therapeutic gastrointestinal fiber endoscopy in Sweden].

Authors:  L Domellöf; B Sandzén
Journal:  Lakartidningen       Date:  1983-09-07

6.  Surgical treatment of adenocarcinoma of the cardia.

Authors:  S Stipa; A Di Giorgio; M Ferri
Journal:  Surgery       Date:  1992-04       Impact factor: 3.982

7.  Gastric cancer survival in Sweden. Lack of improvement in 19 years.

Authors:  G Lundegårdh; H O Adami; B Malker
Journal:  Ann Surg       Date:  1986-11       Impact factor: 12.969

8.  Is the prognosis for Japanese and German patients with gastric cancer really different?

Authors:  E Bollschweiler; K Boettcher; A H Hoelscher; M Sasako; T Kinoshita; K Maruyama; J R Siewert
Journal:  Cancer       Date:  1993-05-15       Impact factor: 6.860

9.  Norwegian multicentre study of survival and prognostic factors in patients undergoing curative resection for gastric carcinoma. The Norwegian Stomach Cancer Trial.

Authors:  T K Haugstvedt; A Viste; G E Eide; O Söreide
Journal:  Br J Surg       Date:  1993-04       Impact factor: 6.939

10.  Gastric carcinoma. A ten-year review.

Authors:  J T Diehl; R E Hermann; A M Cooperman; S O Hoerr
Journal:  Ann Surg       Date:  1983-07       Impact factor: 12.969

View more
  28 in total

1.  Evidence based radiation therapy for locally advanced resectable and unresectable gastric cancer.

Authors:  Georgios V Koukourakis
Journal:  World J Gastrointest Oncol       Date:  2011-09-15

2.  Impact of hospital volume on recurrence and survival after surgery for gastric cancer.

Authors:  Peter C Enzinger; Jacqueline K Benedetti; Jeffrey A Meyerhardt; Sheryl McCoy; Scott A Hundahl; John S Macdonald; Charles S Fuchs
Journal:  Ann Surg       Date:  2007-03       Impact factor: 12.969

3.  Survival benefit of non-curative gastrectomy for gastric cancer patients with synchronous distant metastasis.

Authors:  Chen Li; Min Yan; Jun Chen; Min Xiang; Zheng Gang Zhu; Hao Ran Yin; Yan Zheng Lin
Journal:  J Gastrointest Surg       Date:  2009-11-25       Impact factor: 3.452

4.  Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution.

Authors:  Dong Hoe Koo; Min-Hee Ryu; Baek-Yeol Ryoo; Jinjoo Seo; Mi-Yeon Lee; Heung-Moon Chang; Jae-Lyun Lee; Sung-Sook Lee; Tae Won Kim; Yoon-Koo Kang
Journal:  Gastric Cancer       Date:  2014-05-16       Impact factor: 7.370

5.  Dietary quercetin intake and risk of gastric cancer: results from a population-based study in Sweden.

Authors:  A M Ekström; M Serafini; O Nyrén; A Wolk; C Bosetti; R Bellocco
Journal:  Ann Oncol       Date:  2010-08-05       Impact factor: 32.976

6.  Prognostic factors for advanced gastric cancer: stage-stratified analysis of patients who underwent curative resection.

Authors:  Joong-Min Park; Woo-Sang Ryu; Jong-Han Kim; Sung-Soo Park; Seung-Joo Kim; Chong-Suk Kim; Young-Jae Mok
Journal:  Cancer Res Treat       Date:  2006-02-28       Impact factor: 4.679

7.  Survival trends in patients with gastric and esophageal adenocarcinomas: a population-based study.

Authors:  Sarah J Crane; G Richard Locke; William S Harmsen; Alan R Zinsmeister; Yvonne Romero; Nicholas J Talley
Journal:  Mayo Clin Proc       Date:  2008-10       Impact factor: 7.616

8.  Subclassification of stage IV gastric cancer (IVa, IVb, and IVc) and prognostic significance of substages.

Authors:  Yan Ma; Yingwei Xue; Yanfeng Li; Xiuwen Lan; Yongle Zhang; Ming Zhang
Journal:  J Gastrointest Surg       Date:  2009-12-01       Impact factor: 3.452

9.  Effects of c9,t11-conjugated linoleic acid on adhesion of human gastric carcinoma cell line SGC-7901.

Authors:  Bing-Qing Chen; Yan-Mei Yang; Qi Wang; Yan-Hui Gao; Jia-Ren Liu; Jing-Shu Zhang; Xuan-Lin Wang; Rui-Hai Liu
Journal:  World J Gastroenterol       Date:  2004-05-15       Impact factor: 5.742

10.  The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab.

Authors:  Francesca Di Fabio; Carmine Pinto; Fabiola L Rojas Llimpe; Stefano Fanti; Paolo Castellucci; Ciro Longobardi; Vita Mutri; Chiara Funaioli; Francesca Sperandi; Stefania Giaquinta; Andrea A Martoni
Journal:  Gastric Cancer       Date:  2007-12-25       Impact factor: 7.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.